Cheiron

PhnyX Lab, backed by SK Networks, has introduced Cheiron, Korea’s first generative AI platform for the pharmaceutical industry. Cheiron leverages cutting-edge technology to simplify drug discovery, clinical trials, and production, saving time and resources. Designed for flexibility and efficiency, it’s set to revolutionize medicine and position Korea as a leader in AI-driven healthcare innovation.